{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T16:01:47Z","timestamp":1715616107110},"reference-count":0,"publisher":"BioExcel","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DIC"],"DOI":"10.7573\/dic.212251","type":"journal-article","created":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T11:28:56Z","timestamp":1367321336000},"page":"1-6","source":"Crossref","is-referenced-by-count":2,"title":["Antithrombotic alternatives for stroke prevention in atrial fibrillation: critical differences and remaining questions"],"prefix":"10.7573","author":[{"given":"James","family":"Kalus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10047","published-online":{"date-parts":[[2013,4,16]]},"container-title":["Drugs in Context"],"original-title":[],"link":[{"URL":"https:\/\/www.drugsincontext.com\/wp-content\/uploads\/2014\/05\/dic.212251.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T15:01:42Z","timestamp":1578668502000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.drugsincontext.com\/individual\/antithrombotic-alternatives-for-stroke-prevention-doi-107573-dic.212251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,16]]},"references-count":0,"URL":"https:\/\/doi.org\/10.7573\/dic.212251","relation":{},"ISSN":["1740-4398"],"issn-type":[{"value":"1740-4398","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,16]]}}}